Venture Capital

Demetrix Secures $50M In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

by prnewswire.com posted 1year ago 370 views
EMERYVILLE, Calif., July 11, 2019 /PRNewswire/ -- Today, Demetrix Inc., a biotechnology company focused on the production of cannabinoids, announced that it has secured $50 million in Series A funding. The round was led by Tuatara Capital with participation from existing investor Horizons ...